Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
ALUR
)
1.040
+0.010 (+0.97%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ALUR
< Previous
1
2
3
Next >
Dow Jumps Over 100 Points; US Jobless Claims Increase To 221,000
April 04, 2024
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.34% to 39,259.15 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Allurion Expands Virtual Care Suite to the United States
April 04, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
April 02, 2024
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
March 26, 2024
Via
Benzinga
ALUR Stock Earnings: Allurion Technologies Beats EPS, Beats Revenue for Q4 2023
March 21, 2024
ALUR stock results show that Allurion Technologies beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session
March 21, 2024
Via
Benzinga
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
March 21, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
March 19, 2024
Via
Benzinga
Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
March 13, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Earnings Scheduled For March 21, 2024
March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via
Benzinga
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
March 12, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
March 04, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
February 23, 2024
Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.
Via
Investor's Business Daily
Allurion to Participate in Cowen’s 44th Annual Health Care Conference
February 20, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
February 08, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies
January 29, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
January 24, 2024
Via
Benzinga
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss
January 23, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships
January 17, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities
January 11, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Ozempic Users Might Experience Caloric Intake Rise Post-Discontinuation: Survey
January 08, 2024
Novo Nordisk's Wegovy has been linked to greater weight loss with prolonged use, with 40% of patients still using the drug a year later. This adherence rate is three times higher than other...
Via
Benzinga
Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook
January 08, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program
January 05, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion’s Digital Platform Gains Traction with Expanded Strategic Partnership
January 02, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session
November 20, 2023
Via
Benzinga
Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 20, 2023
Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates...
Via
Benzinga
Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update
November 13, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Participate in the Jefferies London Healthcare Conference
November 06, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Report Third Quarter 2023 Financial Results on November 13, 2023
November 06, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Completes Enrollment in Pivotal AUDACITY Trial for the Allurion Balloon
October 11, 2023
From
Allurion Technologies, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.